IVGIX | VIVAX | IVGIX / VIVAX | |
Total Expense Ratio | 0.64 | 0.17 | 376% |
Annual Report Gross Expense Ratio | 0.64 | 0.17 | 376% |
Fund Existence | 19 years | 33 years | - |
Gain YTD | -10.909 | 9.738 | -112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 154M | 208B | 0% |
Annual Yield % from dividends | 3.43 | 1.97 | 174% |
Returns for 1 year | -11.91 | 4.63 | -257% |
Returns for 3 years | 3.15 | 42.99 | 7% |
Returns for 5 years | 17.68 | 71.78 | 25% |
Returns for 10 years | -7.51 | 129.45 | -6% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRPSX | 29.84 | 0.16 | +0.54% |
Nuveen Large Cap Responsible Eq Prem | |||
JFACX | 38.69 | 0.11 | +0.29% |
JHancock Fundamental All Cap Core R2 | |||
LSOFX | 18.47 | 0.04 | +0.22% |
LS Opportunity Fund Institutional Class | |||
FVCSX | 34.88 | N/A | N/A |
Fidelity Advisor Value Strategies C | |||
EMQAX | 9.84 | -0.02 | -0.20% |
Ashmore Emerging Markets Active Eq A |